DarioHealth · raw details

Digital Therapeutics for Treating Chronic Conditions · Caesarea · Founded 2011

active Public ← back to profile

Highlights

1 patent

About

Digital Therapeutics for Treating Chronic Conditions

DarioHealth is a global digital therapeutics company aiming to revolutionize how people with chronic conditions manage their health, with offerings that include highly rated diabetes and hypertension solutions. The companys AI-powered digital therapeutic solutions are designed to do more than simply support an individuals disease. Dario provides adaptive, personalized experiences that drive behavior change through evidence-based interventions, high-quality software, coaching, and intuitive, clinically proven digital tools to help individuals improve their health and sustain meaningful outcomes. DarioHealth operates at the intersection of life sciences, behavioral science, and software technology and is rapidly expanding into new chronic conditions and geographic markets using a performance-based approach to improve its users health.

Identity

NameDarioHealth
Sluglabstyle-innovations
Former namesLabStyle Innovations
Type / kindstartup
Crunchbase IDlabstyle-innovations
Source _idagxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgL6sq-wIDA

Status

Statusactive
Status reasonPublic on NASDAQ on Feb, 2013;
Last update2026-05-17

Location

HQ country codeIL
HQ region/districtCenter District
HQ cityCaesarea
HQ addressHa-Tokhen Street 8, Caesarea, Israel

Web & social

Websitehttps://www.dariohealth.com
Careers pagehttps://www.dariohealth.com/careers
LinkedInhttps://www.linkedin.com/company/2825359
Twitter / Xhttps://twitter.com/DarioHealth
Facebookhttps://www.facebook.com/DarioHealth
YouTubehttps://www.youtube.com/user/myDario2013
Instagramhttps://www.instagram.com/dariohealth

Classifications

Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcarePatient EngagementDigital Therapeutics
Technologies
Platforms & InterfacesMobileData StorageCloudArtificial IntelligenceMachine Learning
Target customers
Healthcare & Life SciencesHealthcarePatientsProviders
Business models
B2B2CB2CB2B
Tags
diabetespersonalizationchronic-diseaseremote-monitoringiotmobile-applicationsdigital-healthcaremhealthpatient-engagementmhealthreal-timedata-analyticsmonitoringactionable-insightsbig-dataartificial-intelligencemachine-learningchronic-patientsmobile-platformhealthcare-providerstype-2-diabetesseniorsmental-healthdigital-therapeuticscloud-based

Funding

Total raised$244.6M
Current stagePublic
Market cap$76.9M

Raw source document

Show full JSON (0 KB)
{
  "0": "s",
  "1": "l",
  "2": "i",
  "3": "m",
  "4": "p",
  "5": "a",
  "6": "g",
  "7": "e",
  "8": "s",
  "9": "_",
  "10": "i",
  "11": "m",
  "12": "p",
  "13": "o",
  "14": "r",
  "15": "t"
}